Ligand Pharmaceuticals Incorporated
$5.33B- Market cap
- $5.69B
- Debt
- +$374.08M
- Cash
- −$733.52M
Capital structure 94% equity / 6% debt · EV / Revenue 19.90x · EV / EBITDA 33.28x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
LGND · current priceP/E 46.59x
$285.60Latest market snapshot
Implied fair value · at SWKS's multiple
$147.3248.4% below market
6.13 LGND EPS (TTM)×24.03x SWKS P/E=$147.32
Market $285.60Implied $147.32
SWKS · current priceP/E 24.03x
$74.02Latest market snapshot
Implied fair value · at LGND's multiple
$143.5093.9% above market
3.08 SWKS EPS (TTM)×46.59x LGND P/E=$143.50
Market $74.02Implied $143.50